Longitudinal Characterization of SARS-CoV-2 Immunity in Hemodialysis Patients Post Omicron

Authors: Karaba, Andrew H. ¹, Xue, Jiashu ¹, Johnston, Trevor S. ¹, Traut, Caroline C. ¹, Dalrymple, Lorien S. ², Kossmann, Robert J. ², Blankson, Joel N. ¹, Parikh, Chirag R. ^{3, 4, ∗}, Ray, Stuart C. ^{1, 4}

Source: In Kidney International Reports February 2025 10(2):406-415

Discordant performance of mpox serological assays

Authors: Hunt, Joanne H., Jones, Joyce L., Gebo, Kelly A., Hansoti, Bhakti, Traut, Caroline C., Hamill, Matthew M., Keller, Sara C., Gilliams, Elizabeth A., Manabe, Yukari C., Mostafa, Heba H., Fernandez, Reinaldo E., Sanders, Renata A., Cochran, Willa V., Blankson, Joel N., Laeyendecker, Oliver

Source: In Journal of Virological Methods September 2024 329

Mpox Recurrence and Tecovirimat Resistance in a Patient With Advanced Human Immunodeficiency Virus Disease.

Authors: Griffith, David C, Fall, Amary, Carter, Mihaela, Traut, Caroline C, Sop, Joel, Hansoti, Bhakti, Gebo, Kelly A, Mostafa, Heba H, Blankson, Joel N

Source: Open Forum Infectious Diseases; Oct2024, Vol. 11 Issue 10, p1-4, 4p

Subject Terms: VIRUS diseases, HIV, MONKEYPOX, TRANS women, VIRAL genomes

Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+ T cell clonotypes

Authors: Sop, Joel, Traut, Caroline C., Dykema, Arbor G., Hunt, Joanne H., Beckey, Tyler P., Basseth, Christie R., Antar, Annukka A.R., Laeyendecker, Oliver, Smith, Kellie N., Blankson, Joel N.

Source: In Cell Reports Medicine 19 March 2024 5(3)

Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.

Authors: Traut, Caroline C¹ (AUTHOR), Jones, Joyce L¹ (AUTHOR), Sanders, Renata A² (AUTHOR), Clark, Laura R¹ (AUTHOR), Hamill, Matthew M¹ (AUTHOR), Stavrakis, Georgia³ (AUTHOR), Sop, Joel¹ (AUTHOR), Beckey, Tyler P¹ (AUTHOR), Keller, Sara C¹ (AUTHOR), Gilliams, Elizabeth A¹ (AUTHOR), Cochran, Willa V¹ (AUTHOR), Laeyendecker, Oliver^1,4 (AUTHOR), Manabe, Yukari C¹ (AUTHOR), Mostafa, Heba H⁵ (AUTHOR), Thomas, David L¹ (AUTHOR), Hansoti, Bhakti⁶ (AUTHOR), Gebo, Kelly A¹ (AUTHOR) jblanks@jhmi.edu, Blankson, Joel N¹ (AUTHOR) jblanks@jhmi.edu

Source: Journal of Infectious Diseases. 1/15/2024, Vol. 229 Issue 1, p54-58. 5p.

Subject Terms: *MONKEYPOX, *T cells, *VACCINIA, *HIV, *IMMUNOSUPPRESSIVE agents

Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage

Authors: Traut, Caroline C, Blankson, Joel N

Source: In The Lancet Microbe June 2023 4(6):e388-e388

Bivalent mRNA COVID vaccines elicit predominantly cross-reactive CD4+T cell clonotypes

Authors: Sop, Joel, Traut, Caroline C., Dykema, Arbor G., Hunt, Joanne H., Beckey, Tyler P., Basseth, Christie R., Antar, Annukka A.R., Laeyendecker, Oliver, Smith, Kellie N., Blankson, Joel N.

Source: Cell Reports Medicine; March 2024, Vol. 5 Issue: 3

Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones.

Authors: Dragoni, Filippo¹, Kwaa, Abena K.¹, Traut, Caroline C.¹, Veenhuis, Rebecca T.^2,3, Woldemeskel, Bezawit A.¹, Camilo-Contreras, Angelica¹, Raymond, Hayley E.⁴, Dykema, Arbor G.^5,6, Scully, Eileen P.¹, Rosecrans, Amanda M.¹, Smith, Kellie N.^5,6, Bushman, Frederic D.⁴, Simonetti, Francesco R.^1,2 fsimonetti@jhmi.edu, Blankson, Joel N.^1,2 jblanks@jhmi.edu

Source: Journal of Clinical Investigation. 11/1/2023, Vol. 133 Issue 21, p1-13. 13p.